Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-19

FDA Approved: HEMABATE — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for Hemabate (carboprost tromethamine) submitted by Pharmacia & Upjohn Company LLC. The approval updates the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemabate (carboprost trometamol)

Snippet

SUPPL AP for HEMABATE (CARBOPROST TROMETHAMINE)